IP Library Granted Patent US 7,910,719
Granted Patent B2
US 7,910,719 · App. 12/134,420 · Granted Mar 22, 2011

Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,719
App. No.
12/134,420
Granted
Mar 22, 2011
Kind
B2
Abstract

Provided is a nucleic acid primer for LAMP amplification for use in the detection of human papilloma virus and identification of its genotype. The present invention also provides a method of detecting human papilloma virus and identifying its genotype, includes a step of amplifying the nucleic acid chains in a sample in LAMP reaction by using multiple primers including at least one primer selected from the nucleic acid primers according to the present invention and a step of detecting presence of amplified products after the amplification reaction and identifying their genotypes.

Claims (77)

1. A set of isolated nucleic acid primers suitable for LAMP amplification and detection of human papilloma virus genotypes, wherein the set of nucleic acid primers is selected from the group consisting of:

Set 1 consisting of five nucleic acid primers consisting of SEQ ID Nos. 136, 132, 126, 128, and 138;

Set 2 consisting of five nucleic acid primers consisting of SEQ ID Nos. 278, 277, 276, 281 and 280;

Set 3 consisting of five nucleic acid primers consisting of SEQ ID Nos. 527, 524, 526, 523, and 529;

Set 4 consisting of five nucleic acid primers consisting of SEQ ID Nos. 164, 167, 162, 166, and 170;

Set 5 consisting of five nucleic acid primers consisting of SEQ ID Nos. 320, 327, 319, 324, and 328;

Set 6 consisting of five nucleic acid primers consisting of SEQ ID Nos. 454, 457, 453, 456, and 458;

Set 7 consisting of five nucleic acid primers consisting of SEQ ID Nos. 363, 359, 366, 361, and 370;

Set 8 consisting of five nucleic acid primers consisting of SEQ ID Nos. 399, 391, 395, 388, and 402;

Set 9 consisting of five nucleic acid primers consisting of SEQ ID Nos. 474, 476, 477, 475, and 480;

Set 10 consisting of five nucleic acid primers consisting of SEQ ID Nos. 549, 547, 548, 546, and 572;

Set 11 consisting of five nucleic acid primers consisting of SEQ ID Nos. 208, 203, 210, 205, and 214;

Set 12 consisting of five nucleic acid primers consisting of SEQ ID Nos. 251, 244, 248, 242, 255; and

Set 13 consisting of five nucleic acid primers consisting of SEQ ID Nos. 422, 425, 420, 429, and 431.

2. A mixture of primer sets suitable for LAMP amplification and detection of human papilloma virus genotypes, selected from the group consisting of:

Mixture A comprising Set 1, 2 and 3 according to claim 1 ;

Mixture B comprising Set 4, 5 and 6 according to claim 1 ;

Mixture C comprising Set 7, 8, 9 and 10 according to claim 1 ; and

Mixture D comprising Set 11, 12 and 13 according to claim 1 .

3. A detection kit suitable for detecting human papilloma virus genotypes, comprising at least one Primer-Probe Set selected from the group consisting of:

Primer-Probe Set 1 consisting of Set 1 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 600 and 597,

Primer-Probe Set 2 consisting of Set 2 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 654,

Primer-Probe Set 3 consisting of Set 3 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 771 and 768,

Primer-Probe Set 4 consisting of Set 4 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 623,

Primer-Probe Set 5 consisting of Set 5 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 673 and 667,

Primer-Probe Set 6 consisting of Set 6 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 750 and 741,

Primer-Probe Set 7 consisting of Set 7 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 676,

Primer-Probe Set 8 consisting of Set 8 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 699 and 684,

Primer-Probe Set 9 consisting of Set 9 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 752,

Primer-Probe Set 10 consisting of set 10 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 783,

Primer-Probe Set 11 consisting of Set 11 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 630,

Primer-Probe Set 12 consisting of Set 12 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 641, and

Primer-Probe Set 13 consisting of Set 13 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 725 and 713.

4. The kit according to claim 3 , wherein the nucleic acid probe is immobilized on a support surface.

5. The kit according to claim 4 , wherein the support surface is an electrode.

6. A detection kit suitable for detecting human papilloma virus genotypes, comprising at least one Detection Set selected from the group consisting of Detection set A, B, C, and D,

wherein:

Detection Set A comprises:

Primer-Probe Set 1 consisting of Set 1 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 600 and 597,

Primer-Probe Set 2 consisting of Set 2 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 654, and

Primer-Probe Set 3 consisting of Set 3 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 771 and 768;

Detection Set B comprises:

Primer-Probe Set 4 consisting of Set 4 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 623,

Primer-Probe Set 5 consisting of Set 5 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 673 and 667, and

Primer-Probe Set 6 consisting of Set 6 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 750 and 741;

Detection Set C comprises:

Primer-Probe Set 7 consisting of Set 7 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 676,

Primer-Probe Set 8 consisting of Set 8 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 699 and 684, and

Primer-Probe Set 9 consisting of Set 9 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 752, and

Primer-Probe Set 10 consisting of Set 10 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 783; and

Detection Set D comprises:

Primer-Probe Set 11 consisting of Set 11 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 630,

Primer-Probe Set 12 consisting of Set 12 according to claim 1 and a nucleic acid probe consisting of SEQ ID No. 641, and

Primer-Probe Set 13 consisting of Set 13 according to claim 1 and at least one nucleic acid probe consisting of one of SEQ ID Nos. 725 and 713.

7. A detection kit suitable for detecting genotypes of human papilloma virus, comprising at least one mixture of primer sets and a DNA chip,

wherein:

the mixture is selected from the group consisting of:

Mixture A comprising Set 1, 2, and 3 according to claim 1 ;

Mixture B comprising Set 4, 5, and 6 according to claim 1 ;

Mixture C comprising Set 7, 8, 9, and 10 according to claim 1 ; and

Mixture D comprising Set 11, 12, and 13 according to claim 1 ; and

wherein:

the DNA chip comprises nucleic acid probes consisting of:

one of SEQ ID Nos. 600 and 597;

SEQ ID No. 654;

one of SEQ ID Nos. 771 and 768;

SEQ ID No. 623;

one of SEQ ID Nos. 673 and 667;

one of SEQ ID Nos. 750 and 741;

SEQ ID No. 676;

one of SEQ ID Nos. 699 and 684;

SEQ ID No. 752;

SEQ ID No. 783;

SEQ ID No. 630;

SEQ ID No. 641; and

one of SEQ ID Nos. 725 and 713 and

wherein the nucleic acid probes are immobilized on a support surface.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2026
From: CANON MEDICAL SYSTEMS CORPORATION
To: CANON KABUSHIKI KAISHA
Reel/Frame 075315/0598 →
CHANGE OF NAME Recorded Apr 17, 2026
From: TOSHIBA MEDICAL SYSTEMS CORPORATION
To: CANON MEDICAL SYSTEMS CORPORATION
Reel/Frame 075402/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2016
From: KABUSHIKI KAISHA TOSHIBA
To: TOSHIBA MEDICAL SYSTEMS CORPORATION
Reel/Frame 038746/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2008
From: HASHIMOTO, KOJI; ITO, KEIKO; NAKAMURA, NAOKO; HORIUCHI, HIDEKI; HASHIMOTO, MICHIE; SATO, OSAMU
To: KABUSHIKI KAISHA TOSHIBA; SEKISUI MEDICAL CO., LTD.
Reel/Frame 021069/0604 →